Human Centric Drug Discovery

Human Centric Drug Discovery is a biotechnology startup with a focus on improving neurology drug discovery by leveraging human data in the process. Founded in 2021, the company's mission revolves around identifying and validating safe and effective drug targets for neurological diseases, where traditional models have been ineffective.

Their expertise lies in developing, analyzing, and integrating data from induced pluripotent stem cells, large-scale genetics studies, and population health data. This innovative approach allows Human Centric Drug Discovery to address the limitations of current drug discovery processes and pave the way for more targeted and impactful treatments.

The company collaborates with pharmaceutical partners and conducts in-house programs, positioning itself at the forefront of cutting-edge drug discovery research. Notably, they are supported by the venture capital fund Oxford Science Enterprises, which underlines the potential and credibility of their endeavors in the pharmaceutical and life sciences industries.